
CAS 2445259-99-2
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
1 Produkte.
Reozalimab
CAS:Reozalimab (LY3434172) is a bispecific monoclonal antibody targeting PD-1/PD-L1, antitumour and enhances T-cell activation in vitro.Reinheit:95% - 98.1% (SDS-PAGE); 96.2% (SEC-HPLC)Farbe und Form:Liquid

